Association studies of the SAS-ZFAT, IL-23R, IFIH1 and FOXP3 genes in autoimmune thyroid disease

References

• Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev.24, 694–717 (2003).
   PubMed Web of Science ®Google Scholar
• Tomer Y, Davies TF. Infection, thyroid disease and autoimmunity. Endocr. Rev.14, 107–120 (1993).
   PubMed Web of Science ®Google Scholar
• Brix TH, Hansen PS, Kyvik KO, Hegedus L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case–control study. Arch. Intern. Med.160, 661–666 (2000).
   PubMedGoogle Scholar
• Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. The genetics of Grave’s disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab.61, 735–740 (1985).
   PubMed Web of Science ®Google Scholar
• Mangklabruks A, Cox N, DeGroot LJ. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J. Clin. Endocrinol. Metab.73, 236–244 (1991).
   PubMed Web of Science ®Google Scholar
• Heward JM, Allahabadia A, Daykin J et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves’ disease: replication using a population case control and family-based study. J. Clin. Endocrinol. Metab.83, 3394–3397 (1998).
   PubMed Web of Science ®Google Scholar
• Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto’s diseases. Autoimmunity36, 367–379 (2003).
   PubMed Web of Science ®Google Scholar
• Ban Y, Davies TF, Greenberg DA et al. Arginine at position 74 of the HLA-DRb1 chain is associated with Graves’ disease. Genes Immun.5, 203–208 (2004).
   PubMed Web of Science ®Google Scholar
• Simmonds MJ, Howson JM, Heward JM et al. Regression mapping of association between the human leukocyte antigen region and graves disease. Am. J. Hum. Genet.76, 157–163 (2005).
   PubMedGoogle Scholar
• Tomer Y. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid11, 167–169 (2001).
   PubMed Web of Science ®Google Scholar
• Simmonds MJ, Gough SC. Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin. Exp. Immunol.136, 1–10 (2004).
   PubMedGoogle Scholar
• Tomer Y, Concepcion E, Greenberg DA. A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves’ disease. Thyroid12, 1129–1135 (2002).
   PubMed Web of Science ®Google Scholar
• Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab.87, 404–407 (2002).
   PubMed Web of Science ®Google Scholar
• Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SC. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab.88, 5039–5042 (2003).
   PubMed Web of Science ®Google Scholar
• Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.)61, 263–268 (2004).
   PubMedGoogle Scholar
• Dechairo BM, Zabaneh D, Collins J et al. Association of the TSHR gene with Graves’ disease: the first disease specific locus. Eur. J. Hum. Genet.13, 1223–1230 (2005).
   PubMed Web of Science ®Google Scholar
• Hiratani H, Bowden DW, Ikegami S et al. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves’ disease. J. Clin. Endocrinol. Metab.90, 2898–2903 (2005).
   PubMed Web of Science ®Google Scholar
• Kochi Y, Yamada R, Suzuki A et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet.37, 478–485 (2005).
   PubMed Web of Science ®Google Scholar
• Simmonds MJ, Howson JM, Heward JM et al. A novel and major association of HLA-C in Graves’ disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet.16, 2149–2153 (2007).
   PubMed Web of Science ®Google Scholar
• Brand OJ, Lowe CE, Heward JM et al. Association of the interleukin-2 receptor α (IL-2Rα)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf.)66, 508–512 (2007).
   PubMed Web of Science ®Google Scholar
• Smyth D, Cooper JD, Collins JE et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with Type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes53, 3020–3023 (2004).
   PubMed Web of Science ®Google Scholar
• Ichimura M, Kaku H, Fukutani T et al. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves’ disease in a Japanese population. Thyroid18, 625–630 (2008).
   PubMed Web of Science ®Google Scholar
• Shirasawa S, Harada H, Furugaki K et al. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum. Mol. Genet.13, 2221–2231 (2004).
   PubMed Web of Science ®Google Scholar
• Sakai K, Shirasawa S, Ishikawa N et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31–q33 and Hashimoto’s thyroiditis to 8q23–q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet.10, 1379–1386 (2001).
   PubMed Web of Science ®Google Scholar
• Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol.73, 49–56 (2003).
   PubMed Web of Science ®Google Scholar
• McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23–IL-17 immune pathway. Trends Immunol.27, 17–23 (2006).
   PubMed Web of Science ®Google Scholar
• Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol.168, 5699–5708 (2002).
   PubMed Web of Science ®Google Scholar
• Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immunecompetence. J. Immunol.163, 5374–5382 (1999).
   PubMedGoogle Scholar
• Finnegan A, Grusby MJ, Kaplan CD et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through STAT-dependent mechanisms. J. Immunol.169, 3345–3352 (2002).
   PubMed Web of Science ®Google Scholar
• Chitnis T, Najafian N, Benou C et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest.108, 739–747 (2001).
   PubMed Web of Science ®Google Scholar
• Afanasyeva M, Wang Y, Kaya Z et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-γ-independent pathway. Circulation104, 3145–3151 (2001).
   PubMed Web of Science ®Google Scholar
• Wang W, Ostlie NS, Conti-Fine BM, Milani M. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells. J. Immunol.172, 97–103 (2004).
   PubMedGoogle Scholar
• Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O’Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev.202, 139–156 (2004).
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science314, 1461–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Farago B, Magyari L, Safrany E et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann. Rheum. Dis.67, 248–250 (2008).
   PubMed Web of Science ®Google Scholar
• Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet.80, 273–280 (2007).
   PubMed Web of Science ®Google Scholar
• Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y. IL-23R is a major susceptibility gene for Graves’ ophthalmopathy: the IL-23/Th17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab.93, 1077–1081 (2008).
   PubMed Web of Science ®Google Scholar
• Ban Y, Tozaki T, Taniyama M et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity42, 126–130 (2009).
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Kikuchi M, Matsumoto K et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol.175, 2851–2858 (2005).
   PubMed Web of Science ®Google Scholar
• Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature442, 39–44 (2006).
   PubMed Web of Science ®Google Scholar
• Lonnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes49, 1314–1318 (2000).
   PubMedGoogle Scholar
• Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a Type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet.38, 617–619 (2006).
   PubMed Web of Science ®Google Scholar
• Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev.15, 788–830 (1994).
   PubMed Web of Science ®Google Scholar
• Wick G, Grubeck-Loebenstein B, Trieb K, Kalischnig G, Aguzzi A. Human foamy virus antigens in thyroid tissue of Graves’ disease patients. Int. Arch. Allergy Immunol.99, 153–156 (1992).
   PubMed Web of Science ®Google Scholar
• Matsuda T, Tomita M, Uchihara JN et al. Human T cell leukemia virus type I-infected patients with Hashimoto’s thyroiditis and Graves’ disease. J. Clin. Endocrinol. Metab.90, 5704–5710 (2005).
   PubMed Web of Science ®Google Scholar
• Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-α induced thyroiditis: toward a new classification. Hepatology43, 661–672 (2006).
   PubMed Web of Science ®Google Scholar
• Sutherland A, Davies J, Owen CJ et al. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves’ disease susceptibility. J. Clin. Endocrinol. Metab.92, 3338–3341 (2007).
   PubMed Web of Science ®Google Scholar
• Zhao ZF, Cui B, Chen HY et al. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves’ disease in Chinese population. Endocrine32, 143–147 (2007).
   PubMedGoogle Scholar
• Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol.2, 816–822 (2001).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev.182, 18–32 (2001).
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet.27, 68–73 (2001).
   PubMed Web of Science ®Google Scholar
• Walker R, Kasprowicz DJ, Gersuk VH et al. Induction of FOXP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest.112, 1437–1443 (2003).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4, 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science299, 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko S-A, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.4, 337–342 (2003).
   PubMed Web of Science ®Google Scholar
• Walker LSK, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med.198, 249–258 (2003).
   PubMed Web of Science ®Google Scholar
• Chatila TA, Blaeser F, Ho N et al.JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest.106, R75–R81 (2000).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet.27, 20–21 (2001).
   PubMed Web of Science ®Google Scholar
• Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet.27, 18–20 (2001).
   PubMed Web of Science ®Google Scholar
• Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet.39, 537–545 (2002).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Brunkow M, Ramsdell F et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA–>AAUGAA) leads to the IPEX syndrome. Immunogenetics53, 435–439 (2001).
   PubMed Web of Science ®Google Scholar
• Kobayashi I, Shiari R, Yamada M et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J. Med. Genet.38, 874–876 (2001).
   PubMed Web of Science ®Google Scholar
• Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol.15, 430–435 (2003).
   PubMed Web of Science ®Google Scholar
• Owen CJ, Jennings CE, Imrie H et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J. Clin. Endocrinol. Metab.88, 6034–6039 (2003).
   PubMed Web of Science ®Google Scholar
• Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest.109, 131–140 (2002).
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz H-M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med.199, 1285–1291 (2004).
   PubMed Web of Science ®Google Scholar
• Huan J, Culbertson N, Spencer L et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res.81, 45–52 (2005).
   PubMed Web of Science ®Google Scholar
• Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF. Mapping the major susceptibility loci for familial Graves’ and Hashimoto’s diseases: evidence for genetic heterogeneity and gene interactions. J. Clin. Endocrinol. Metab.84, 4656–4664 (1999).
   PubMed Web of Science ®Google Scholar
• Taylor JC, Gough SC, Hunt PJ et al. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J. Clin. Endocrinol. Metab.91, 646–653 (2005).
   PubMedGoogle Scholar
• Imrie H, Vaidya B, Perros P et al. Evidence for a Graves’ disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J. Clin. Endocrinol. Metab.86, 626–630 (2001).
   PubMedGoogle Scholar
• Tomer Y, Ban Y, Concepcion E et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet.73, 736–747 (2003).
   PubMed Web of Science ®Google Scholar
• Ebers GC, Kukay K, Bulman DE et al. A full genome search in multiple sclerosis. Nat. Genet.13, 472–476 (1996).
   PubMed Web of Science ®Google Scholar
• Cornélis F, Fauré S, Martinez M et al.ECRAF. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl Acad. Sci. USA95, 10746–10750 (1998).
   PubMed Web of Science ®Google Scholar
• Cucca F, Goy JV, Kawaguchi Y et al. A male–female bias in Type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat. Genet.19, 301–302 (1998).
   PubMedGoogle Scholar
• Bassuny WM, Ihara K, Sasaki Y et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with Type 1 diabetes. Immunogenetics55, 149–156 (2003).
   PubMed Web of Science ®Google Scholar
• Zavattari P, Deidda E, Pitzalis M et al. No association between variation of the FOXP3 gene and common Type 1 diabetes in the Sardinian population. Diabetes53, 1911–1914 (2004).
   PubMed Web of Science ®Google Scholar
• Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH. Genetic association studies of the FOXP3 gene in Graves’ disease and autoimmune Addison’s disease in the United Kingdom population. J. Mol. Endocrinol.37, 97–104 (2006).
   PubMed Web of Science ®Google Scholar
• Ban Y, Tozaki T, Tobe T et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun.28, 201–207 (2007).
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW. MHC-linked susceptibility to Type 1 diabetes: a structural perspective. Ann. NY Acad. Sci.1005, 119–127 (2003).
   PubMedGoogle Scholar
• Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to Type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev.29, 697–725 (2008).
   PubMed Web of Science ®Google Scholar
• Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J. Clin. Endocrinol. Metab.90, 4904–4911 (2005).
   PubMedGoogle Scholar
• Ikegami H, Awata T, Kawasaki E et al. The association of CTLA4 polymorphism with Type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab.91, 1087–1092 (2006).
   PubMedGoogle Scholar
• Howson JM, Dunger DB, Nutland S, Stevens H, Wicker LS, Todd JA. A Type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia50, 741–746 (2007).
   PubMed Web of Science ®Google Scholar
• Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly G. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunothyroiditis and autoimmune diabetes. Thyroid19, 143–148 (2009).
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Kalima P, Taheri S, Beattie TF. Streptococcus A in paediatric accident and emergency: are rapid streptococcal tests and clinical examination of any help? Inflamm. Bowel Dis.13, 338–355 (2006).
   Google Scholar
• Devlin SM, Yang H, Ippoliti A et al.NOD2 variants and antibody response to microbial antigens in Crohn’s disease patients and their unaffected relatives. Gastroenterology132, 576–586 (2007).
   PubMed Web of Science ®Google Scholar
• Sawai Y, DeGroot LJ. Binding of human thyrotropin receptor peptides to a Graves’ disease-predisposing human leukocyte antigen class II molecule. J. Clin. Endocrinol. Metab.85, 1176–1179 (2000).
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature423, 506–511 (2003).
   PubMed Web of Science ®Google Scholar
• Ban Y, Davies TF, Greenberg DA et al. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun.4, 586–593 (2003).
   PubMed Web of Science ®Google Scholar
• Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J. Immunol.165, 6606–6611 (2000).
   PubMed Web of Science ®Google Scholar
• Xu Y, Graves P, Tomer Y, Davies T. CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol.215, 133 (2002).
   PubMed Web of Science ®Google Scholar
• Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves’ disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology146, 2684–2691 (2005).
   PubMed Web of Science ®Google Scholar